Education Information
2017 - Continues
2017 - ContinuesPost Doctorate of Medicine
Istanbul University, İstanbul Tıp Fakultesi-Onkoloji Enstitüsü, Tıbbi Onkoloji, Turkey
2012 - 2016
2012 - 2016Expertise In Medicine
Istanbul University, Cerrahpaşa Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Turkey
2005 - 2011
2005 - 2011Undergraduate
Istanbul University, Cerrahpaşa Tıp Fakültesi, İngilizce Tıp, Turkey
Dissertations
2016
2016Expertise In Medicine
MEME KANSERİNDE NEOADJUVAN KEMOTERAPİ YANITINI
PREDİKTE EDEN PATOLOJİK FAKTÖRLER
Istanbul University, Cerrahpaşa Tıp Fakultesi, İç Hastalıkları Anabilim Dalı
Certificates, Courses and Trainings
2018
2018PSİKOONKOLOJİ 2. DÜZEY KLİNİSYEN EĞİTİMİ
Education Management and Planning
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
2017
2017AİLE DANIŞMANLIĞI
Education Management and Planning
ULUDAĞ ÜNİVERSİTESİ-UZAKTAN EĞİTİM
2017
2017İMMUNOONKOLOJİ KURSU
Health&Medicine
TÜRK TIBBİ ONKOLOJİ DERNEĞİ
2017
2017PSİKOONKOLOJİ 1. DÜZEY KLİNİSYEN EĞİTİMİ
Education Management and Planning
PSİKONET-UZM. PSİKOLOG ESRA SAVAŞ KAPLAN BİREYSEL EĞİTİMİ
Research Areas
Medicine
Health Sciences
Internal Medicine Sciences
Internal Diseases
Oncology
Academic Titles / Tasks
2017 - Continues
2017 - ContinuesResearch Assistant
Istanbul University, Istanbul Medical Faculty, Tıbbi Onkoloji
Published journal articles indexed by SCI, SSCI, and AHCI
2022
2022The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)
Hizal M., Bilgin B., Paksoy N., Atci M. M. , KAHRAMAN S., Kilickap S., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022 (SCI-Expanded)
2022
2022The Predictive Importance of Body-Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Emirzeoglu L., Arici S., Sahin A. B. , Ocak B., Ak N., Ay S., et al.
BREAST CARE, 2022 (Peer-Reviewed Journal)
2022
2022Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study
Hizal M., Bilgin B., Paksoy N., Kilickap S., Atci M. M. , KAHRAMAN S., et al.
FUTURE ONCOLOGY, vol.18, pp.2573-2582, 2022 (SCI-Expanded)
2022
2022Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.
Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.
JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.16, 2022 (SCI-Expanded)
2022
2022Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study
BAŞOĞLU TÜYLÜ T., Sakin A., Erol C., Ozden E., ÇABUK D., Cilbir E., et al.
JOURNAL OF CHEMOTHERAPY, 2022 (SCI-Expanded)
2022
2022Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer
Minareci Y., Sozen H., Ak N., Tosun O. A. , Saip P., Salihoglu M. Y. , et al.
CHEMOTHERAPY, vol.67, pp.1-11, 2022 (SCI-Expanded)
2021
2021Nivolumab treatment for metastatic thymic epithelial tumors.
Ak N., Aydiner A.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.27, pp.1710-1715, 2021 (SCI-Expanded)
2021
2021Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.
TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.29, no.4, pp.487-495, 2021 (SCI-Expanded)
2021
2021Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.19, no.1, 2021 (SCI-Expanded)
2021
2021Skeletal system as a rare metastatic site in patients with ovarian carcinoma
Ak N. , Minareci Y. , Saip P.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.31, no.8, pp.1125-1131, 2021 (Peer-Reviewed Journal)
2021
2021Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
Cil I., Kucukarda A., Atci M. M. , Secmeler S., Paksoy N., Ferhatoglu F., et al.
TUMORI JOURNAL, 2021 (SCI-Expanded)
2021
2021The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study
Hizal M., Bilgin B., Paksoy N., Acikgoz O., Sezer A., Gurbuz M., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021 (SCI-Expanded)
2021
2021Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.
Paksoy N., Erdem S., Karaca M., Ak N., Pehlivan M., Yirgin İ., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, no.0, 2021 (SCI-Expanded)
2021
2021Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
Bahceci A., PAYDAŞ S., Ak N., Ferhatoglu F., Saip P. M. , SEYDAOĞLU G., et al.
CANCER INVESTIGATION, 2021 (SCI-Expanded)
2021
2021The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study
Ak N., Ozkan B., Yenigun M. B. , Yilmazbayhan D., Toker A., Ferhatoglu F., et al.
JOURNAL OF BUON, vol.26, no.3, pp.819-829, 2021 (SCI-Expanded)
2021
2021Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.
Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded)
2021
2021Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors.
Ferhatoglu F., Paksoy N., Dogan I., Ak N., Pehlivan M., Ekenel M., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded)
2021
2021Dramatic response to single-agent atezolizumab in a patient with MSI-H serous ovarian cancer
Ak N., Vatansever S.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021 (SCI-Expanded)
2020
2020Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment
Karanlik H., CABIOĞLU N., Oprea A. L. , ÖZGÜR İ., AK N., AYDINER A., et al.
BREAST CARE, 2020 (SCI-Expanded)
2020
2020"Door to Treatment" Outcomes of Cancer Patients during the COVID-19 Pandemic
Ak N., Vatansever S.
CHEMOTHERAPY, 2020 (SCI-Expanded)
2020
2020Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tüzer C., Sarı M., Aktaş Ç., Ak N., Büyüköztürk S., Çolakoğlu B., et al.
ALLERGY, vol.75, no.11, pp.2942-2946, 2020 (SCI-Expanded)
2020
2020Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
Celik E., Kizildag Yirgin I., Goksever Celik H., Engin G., Sozen H., Ak N., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2020 (SCI-Expanded)
2020
2020Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)
Alkan A., Yasar A., Guc Z. G. , Gurbuz M., BAŞOĞLU TÜYLÜ T., SEZGİN GÖKSU S., et al.
EUROPEAN JOURNAL OF CANCER CARE, 2020 (SCI-Expanded)
2019
2019IS CHEMOTHERAPY BETTER FOR EARLY STAGE HIGH RISK HISTOLOGIC TYPES OF ENDOMETRIAL CANCER
ÇELİK E. G. , AK N., SÖZEN H., SAİP P. M. , TOPUZ S.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.29, 2019 (SCI-Expanded)
2019
2019The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study
Eralp Y., Ak N., Yilmazbayhan D., Ozkan B., Ferhatoglu F., Demirkazik A., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (Peer-Reviewed Journal)
2019
2019Outcomes of Thymoma and Determinants of Survival: 16 Years Experience of a Tertiary Cancer Center
Ak N., Toker A., Bayraktar S., Ozkan B., Ülker M. B. C. , Dagoglu N., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (SCI-Expanded)
2019
2019Feasibilty of sentinel lymph node biopsy in patients with node-positive inflammatory breast cancer who responded to neoadjuvant systemic treatment
OPREA A. -. , Ak N., Saip P., Onder S., Bademler S., Gulluoglu B. M. , et al.
BREAST, vol.44, 2019 (SCI-Expanded)
2019
2019Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.
Keskin S., Kucucuk S., Ak N., ATALAR B., Sari M., Sozen H., et al.
Oncology research and treatment, vol.42, no.3, pp.101-106, 2019 (SCI-Expanded)
Articles Published in Other Journals
2021
2021Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study
Ak N., Ciftci R., Cabioglu N., Aydiner A.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.2, pp.215-221, 2021 (ESCI)
2021
2021Nectin-2 and Nectin-4 Adhesion Molecules in Patients with Breast Cancer
Ak N., Serilmez M., Ucuncu M. Z. , Bademler S., Vatansever S.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.2, pp.165-170, 2021 (ESCI)
Refereed Congress / Symposium Publications in Proceedings
2020
2020Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience
DOĞAN İ., AYDIN E. M. , AK N., İBİŞ K., Sukruoglu Ö., Erciyas S., et al.
ESMO Asia Virtual Congress, ELECTR NETWORK, 20 - 22 November 2020, vol.31
2019
2019Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
Karabulut S., Dogan I., Ak N. , Afsar C. U. , Karabulut M., Tastekin D.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.305
2019
2019Does nutritional status affect treatment tolerability, response and survival in metastatic gastric cancer patients? Results of prospective multicenter study
AK N.
European Society for Medical Oncology Congress 2019, Barcelona, Spain, 27 September - 01 October 2019, pp.424-430
2019
2019THE ROLE ADJUVANT CHEMOTHERAPY IN RESECTED STAGE 1 NSCLC WITH HIGH RISK FACTORS: A TURKISH ONCOLOGY GROUP STUDY
AK N.
World Conferrence of Lung Cancer 2019, Barcelona, Spain, 7 - 10 September 2019, pp.933-934
2019
2019OUTCOMES OF THYMOMA AND DETERMINANTS OF SURVIVAL: 16 YEARS EXPERIENCE OF A TERTIARY CANCER CENTER
AK N.
World Conferrence of Lung Cancer, Barcelona, Spain, 7 - 10 September 2019, pp.1095-1096
2019
2019Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
Tuzer O. C. , Sari M., Aktas E., Ak N. , Buyukozturk S., Colakoglu B., et al.
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.737-738
2019
2019Significance of adiposity in endometrial cancer prognosis.
KIZILDAĞ YIRGIN İ., ENGİN G., ÇELİK E., TOPUZ S., AK N., SAİP P.
Türk manyetik rezonans derneği.24.Uluslararası katılımlı yıllık bilimsel toplantısı. 2019, Ankara, Turkey, 25 - 27 April 2019
2018
2018Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29
Tüzer Ö. C. , Sarı M., ÇETİN E., Ak N., BÜYÜKÖZTÜRK S., ÇOLAKOĞLU B., et al.
XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Turkey, 17 - 21 November 2018, pp.111
2013
2013IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E. , AR M. C. , et al.
39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, no.261, pp.277-278
2012
2012IVIG sonrası akut miyokard enfarktüsü gelişen iki ITP olgusu
BAVUNOĞLU I., EYİCE D., AK N., ELVERDI T., EŞKAZAN A. E. , AR M. C. , et al.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, no.261, pp.277-278
Books & Book Chapters
2019
2019Endometrium Kanserleri
AK N.
in: Klinik Çalışmalarla Onkolojide Hedefli Tedaviler, CİHAN S, GEREDELİ Ç, DEMİR C., Editor, Tıbbi Yayınlar Merkezi, İstanbul, pp.113-122, 2019
2019
2019Systemic Treatment Drugs/Regimens and Dose Modifications
AK N.
in: Breast Disease, Aydiner A., Igci A., Soran A., Editor, Springer, Cham, Isviçre, pp.789-801, 2019
2018
2018